Back to search
Pneumococcal Immunisation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pneumococcal Immunisation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pneumococcal Immunisation trials you may qualify forThis is a phase 3 randomized, modified double-blind study whose purpose is to measure whether 3 lots of the investigational pneumococcal vaccine PCV21 can help…
Streptococcus pneumoniae is responsible for serious infections associated to numerous hospitalizations and high rate of mortality. The incidence and therefore t…
The study will evaluate the safety, tolerability, and immunogenicity of VAX-31 in adults ≥50 years of age.
The purpose of this study is to understand the safety of Prevenar 20 (Pneumococcal 20-valent conjugate vaccine) once it is out in the Korean market. Prevenar 20…
To learn how radiation treatment may affect your responses to vaccines against pneumonia.
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
This study is a Phase 3, randomized, modified double-blind study which aims to measure whether PCV21 vaccine (investigational pneumococcal conjugate vaccine) is…
This study is a Phase 3, randomized, modified double-blind study which aims to document the safety profile of the PCV21 vaccine (investigational pneumococcal va…